Curr. Opin. Drug Disc. & Dev.; 2006; 9, (3), 303-313.

Computational Approaches to the Prediction of Blood-Brain Barrier Permeability: A Comparative Analysis of Central Nervous System Drugs versus Secretase Inhibitors for Alzheimer's Disease

Gilbert M. Rishton, Kristen LaBonte, Anthony J. Williams, Karim Kassam & Eduard Kolovanov

Abstract

This review summarizes progress made in the development of fully computational approaches to the prediction of blood-brain barrier (BBB) permeability of small molecules, with a focus on rapid computational methods suitable for the analysis of large compound sets and virtual screening. A comparative analysis using the recently developed Advanced Chemistry Development (ACD/Labs) Inc BBB permeability algorithm for the calculation of logBB values for known Alzheimer's disease medicines, selected central nervous system drugs and new secretase inhibitors for Alzheimer's disease, is presented. The trends in logBB values and the associated physiochemical properties of these agents as they relate to the potential for BBB permeability are also discussed.

To download this article, visit the BioMed Web Site.